Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P61278 (
somatostatin
)
22,083
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mechanisms regulating peptidergic, noradrenergic and cholinergic development were compared in dissociated cell cultures of neonatal rat sympathetic ganglia. The majority of cultured neurons contained at least two neurotransmitters and many neurons contained three or more. These studies were undertaken to determine whether co-existing transmitters were co-ordinately regulated by the environment. Co-culture of sympathetic neurons with ganglion non-neuronal cells increased substance P and
choline acetyltransferase
activity but decreased
somatostatin
and tyrosine hydroxylase activity. Conversely, elimination of non-neuronal cells virtually abolished neuronal expression of substance P and
choline acetyltransferase
and increased
somatostatin
and tyrosine hydroxylase. Consequently, under these conditions,
somatostatin
and tyrosine hydroxylase were similarly regulated, whereas substance P was associated with
choline acetyltransferase
. By contrast, stimulation of adenylate cyclase or treatment with membrane-permeable adenosine 3',5'-phosphate analogs increased tyrosine hydroxylase and decreased
choline acetyltransferase
, but had no effect on substance P or
somatostatin
levels. Moreover, potassium- or veratridine-induced membrane depolarization increased tyrosine hydroxylase but decreased substance P,
somatostatin
and norepinephrine levels. However, inhibition of neurotransmitter release with magnesium or calcium-free medium prevented the decrease in norepinephrine levels but not the decrease in substance P and
somatostatin
. Consequently, the effects of membrane depolarization on peptide levels cannot be ascribed to release and subsequent depletion of substance P and
somatostatin
and must result from decreased net synthesis (synthesis minus catabolism) of the transmitters. Nerve growth-factor treatment also differentially regulated transmitter metabolism; nerve growth factor increased protein-specific activities of tyrosine hydroxylase and
choline acetyltransferase
but did not increase the protein-specific content of substance P and
somatostatin
. Quantitative transmitter expression was also influenced by neuron density; increasing density elevated substance P and
choline acetyltransferase
activity but decreased
somatostatin
and tyrosine hydroxylase activity per neuron. Finally, culture of sympathetic neurons in a defined (serum-free) medium also altered some but not all traits, decreasing substance P,
somatostatin
and
choline acetyltransferase
without any change in tyrosine hydroxylase.(ABSTRACT TRUNCATED AT 400 WORDS)
...
PMID:Differential regulation of peptide and catecholamine characters in cultured sympathetic neurons. 241 73
The development of substance P,
somatostatin
, and
choline acetyltransferase
activity was examined in embryonic rat striatum in vivo and in culture. The study was undertaken to help define mechanisms by which diverse neurotransmitter phenotypes may be regulated within the same structure in the brain. Choline acetyltransferase (CAT) was present in striatum before gestational Day 13.5 (E13.5), and enzyme levels increased continually between E13.5 and birth. By contrast, substance P (SP) and
somatostatin
(SS) did not develop in vivo until E15, and peptide levels fluctuated between E15 and birth, indicating that striatal peptidergic and cholinergic development were regulated differently. To define mechanisms mediating the differential regulation of striatal peptidergic and cholinergic neurons, neurotransmitter development was examined in embryonic striatum in vitro. Cultured striatal neurons from E13.5 embryos expressed substance P and
somatostatin
de novo after several days in culture, and peptide levels and CAT activity increased significantly in vitro. Each transmitter phenotype was regulated in vitro by a different constellation of environmental factors, and many factors differentially influenced SP, SS, and CAT development. For example, coculture of striatum with a target tissue, the ventral mesencephalon (substantia nigra), increased CAT activity and SP levels but had no significant effect on levels of SS. Moreover, there were widely differing effects on CAT, SP, and SS development of medium conditioned by exposure to a variety of cell types, indicating that the three transmitter systems were regulated by different soluble factors. Potassium-induced membrane depolarization also exerted different effects on the different transmitter traits, elevating CAT activity but decreasing SP and SS. Finally, insulin was required for the survival of SP-containing neurons, but not for the survival of SS- or CAT-containing neurons, indicating that the survival of different populations of striatal neurons was dependent upon different factors. Our observations suggest that different populations of neurons in the striatum are regulated by different mechanisms, so that alterations in the environment may produce strikingly diverse responses in the development of different phenotypic traits within the same structure.
...
PMID:Differential regulation of cholinergic and peptidergic development in the rat striatum in culture. 241 2
We have developed procedures for dissociating neurons from the myenteric plexus of the small intestine of newborn rats and for growing those neurons in cell cultures for up to 3 months. Neurons in these cultures retain many of the differentiated properties of myenteric neurons in vivo. This is the first of a series of 3 papers describing those properties. In this paper, we describe the morphology of cultured neurons that we have observed with light and electron microscopy; we also describe the patterns of straining observed when immunocytochemical techniques were used to localize neurotransmitter candidates in the cultured neurons. Intracellular injections of a fluorescent dye, Lucifer yellow, revealed that many of the cultured neurons had morphologies similar to those of myenteric neurons in vivo. When thin sections of cultures were viewed in an electron microscope, many neurons were observed to have numerous small (40-60 nm), clear synaptic vesicles and/or large (80-150 nm), opaque-cored (p-type) vesicles. Synaptic profiles were most often observed on neuronal somata. Neurons containing immunoreactive serotonin, substance P,
somatostatin
, enkephalin, bombesin and gastrin/cholecystokinin were observed in about the same proportions as they occur in the intact myenteric plexus. Neurons containing immunoreactive vasoactive intestinal polypeptide were found in higher numbers than reported in vivo. Neurons containing immunoreactive neurotensin, secretin and glutamate decarboxylase were not observed. An antiserum directed against
choline acetyltransferase
stained 40-50% of the neurons. We conclude that myenteric neurons continue to express much of their normal differentiated properties even when they are removed from the gut, dissociated into a suspension of single cells and grown in culture. Such cultures will be useful for correlating the morphological, biophysical, pharmacological and synaptic properties of individual myenteric neurons and for testing the ability of altered environmental conditions to change those properties.
...
PMID:Neurons dissociated from rat myenteric plexus retain differentiated properties when grown in cell culture. I. Morphological properties and immunocytochemical localization of transmitter candidates. 242 14
Levels of
somatostatin
, noradrenaline, dopamine, 5-hydroxytryptamine and 5-hydroxyindoleacetic acid were unchanged in rat neocortex 3 or 6 months after ibotenic acid lesion of the ipsilateral nucleus basalis that reduced cortical
choline acetyltransferase
levels by over 60%. These results render unlikely the possibility that non-cholinergic neurotransmitter deficits in Alzheimer's disease cortex are the consequence of cholinergic degeneration.
...
PMID:Maintenance of cortical somatostatin and monoamine levels in the rat does not require intact cholinergic innervation. 243 18
The enzyme activities of glutamic acid decarboxylase (GAD), tyrosine hydroxylase (TH) and
choline acetyltransferase
(
ChAT
) and concentrations of substance P (SP) and
somatostatin
were determined in the cerebellum of macaque monkey (Macaca fuscata fuscata) at 3 different ages, embryonic 4 months, embryonic 5.5 months (full-term) and adult. Similar graded increases in the activities of GAD and TH were observed during development. In contrast,
ChAT
activity was relatively high at embryonic 4 months, increased about twofold between embryonic 4 months and 5.5 months, but did not change between embryonic 5.5 months and adult. These findings suggest that noradrenergic terminals develop synchronously with GABAergic interneurons. On the other hand, the innervation by
ChAT
-containing fibers is completed during the prenatal period. The concentrations of
somatostatin
and SP were high at embryonic 4 months, and decreased to, respectively, about 1/18 and 1/4 (expressed per g weight) in adult animals. Several interpretations of the decrease of the two neuropeptides in cerebellar tissue during ontogeny are discussed.
...
PMID:Ontogeny of glutamic acid decarboxylase, tyrosine hydroxylase, choline acetyltransferase, somatostatin and substance P in monkey cerebellum. 243 22
Somatostatin
immunoreactivity was studied in the avian ciliary ganglion by immunocytochemistry and radioimmunoassay. Immunoreactivity was localized to small diameter cell bodies of neurons from embryos, newly-hatched and adult preparations. Immunostaining of ganglia with a mixture of antisera to substance P and monoclonal antibody to
somatostatin
indicated that a number of
somatostatin
-immunoreactive neurons were surrounded by substance P-immunoreactive boutons, which characteristically terminate on choroidal neurons. Staining with a mixture of antisera to
choline acetyltransferase
and antibody to
somatostatin
showed that the
somatostatin
-immunoreactive neurons were less intensely-stained for
choline acetyltransferase
than were the neurons lacking
somatostatin
immunoreactivity. Bundles of nerve fibers showing
somatostatin
and
choline acetyltransferase
immunoreactivity were found in the choroid layers of the eye. Radioimmunoassay indicated the presence of
somatostatin
immunoreactivity in both chick and quail ganglia; the
somatostatin
immunoreactivity eluted from high pressure liquid chromatography in the same positions as authentic
somatostatin
14 and 28. These results show that
somatostatin
is contained in cholinergic choroidal neurons in the chick and quail ciliary ganglion.
...
PMID:Cholinergic neurons of the chicken ciliary ganglion contain somatostatin. 245 84
Galanin-like immunoreactivity (GLI) was measured in baboon brains using a recently developed radioimmunoassay. Concentrations were measured in 10 cortical regions, hippocampus and 20 subcortical regions. The highest concentrations were in the median eminence, followed by hypothalamus, locus ceruleus, periaqueductal grey, bed nucleus of the stria terminalis, septum, amygdala and substantia innominata. Substantial amounts were also measurable in the inferior olive, basal ganglia and thalamus with very low levels in cerebellum. In cerebral cortex, concentrations were lowest in occipital cortex and highest in dorsolateral frontal cortex. Hippocampal concentrations were higher than those in cerebral cortex. Concentrations of GLI in cerebral cortex were significantly correlated with
choline acetyltransferase
activity and substance P immunoreactivity but not with concentrations of
somatostatin
or neuropeptide Y. Approximately half the GLI coeluted with porcine standards while half corresponded to a lower molecular weight species on gel permeation chromatography. With reverse phase high performance liquid chromatography (HPLC) the majority of the immunoreactivity eluted just in front of the porcine standard with a smaller amount coeluting with the porcine standard. These results show a widespread distribution of GLI in primate brain and are in accord with previous immunocytochemical studies.
...
PMID:Distribution of galanin-like immunoreactivity in baboon brain. 246 42
The basal forebrain magnocellular complex of primates is defined by the presence of large, hyperchromic, usually cholinergic neurons in the nucleus basalis of Meynert and nucleus of the diagonal band of Broca. Because there is growing evidence for noncholinergic neuronal elements in the basal forebrain complex, five neuropeptides and the enzyme
choline acetyltransferase
were studied immunocytochemically in this region of rhesus monkeys. Galaninlike immunoreactivity coexists with choline-acetyl-transferase-like immunoreactivity in most large neurons and in some smaller neurons of the primate nucleus basalis and nucleus of the diagnonal band. Four other peptides show immunoreactivity in more limited regions of the basal forebrain complex, usually in separate smaller, noncholinergic neurons. Numerous small, somatostatinlike-immunoreactive neurons occupy primarily anterior and intermediate segments of the nucleus basalis, especially laterally and ventrally. Somewhat fewer, small neuropeptide Y-like-immunoreactive somata are found in the same regions. Neurons that show neurotensinlike immunoreactivity are slightly larger than cells that contain immunoreactivity for
somatostatin
or neuropeptide Y, but these neurons also occur mainly in anterior and intermediate parts of the nucleus basalis. Overall, the usually small, leucine-enkephalin-like-immunoreactive neurons are infrequent in the basal forebrain complex and are most abundant in the rostral intermediate nucleus basalis. Thus, neurons that appear to contain
somatostatin
, neuropeptide Y, neurotensin, or enkephalin mingle with cholinergic/galaninergic neurons only in some subdivisions of the nucleus basalis/nucleus of the diagonal band, and their distributions suggest that some of these small neurons could be associated with structures that overlap with cholinergic neurons of the labyrinthine basal forebrain magnocellular complex. We also have found light microscopic evidence for innervation of basal forebrain cholinergic neurons by boutons that contain galanin-,
somatostatin
-, neuropeptide Y-, neurotensin-, or enkephalinlike immunoreactivity. The origins and functions of these putative synapses remain to be determined.
...
PMID:Peptidergic neurons in the basal forebrain magnocellular complex of the rhesus monkey. 246 77
The septo-hippocampal neurons (SHNs), located in the medial septum, project to the hippocampal formation. The population of SHNs, as shown by single unit recordings in urethane-anesthetized rats, is heterogeneous, both in terms of patterns of spontaneous activity (a significant proportion of the SHNs display a characteristic rhythmically bursting activity at about 4 Hz) and of conduction velocity. Their average rate of spontaneous discharge is quite high (20 impulses per second). They are excited by the iontophoretic application of acetylcholine and various cholinergic agonists. They are also excited by some peptides such as substance P and TRH. Parallel studies in aged animals show that the physiological properties of the SHNs are altered, while their pharmacological properties seem to be unchanged. Immunohistochemical investigations using antibodies against various peptides and a monoclonal antibody against
choline acetyltransferase
(
ChAT
) show that SHNs retrogradely-labeled from the hippocampus often contain
ChAT
, less frequently galanin-like immunoreactivity and in a few cases enkephalin, luteinizing hormone-releasing hormone, or calcitonin gene-related peptide. In contrast, cholecystokinin, vasoactive intestinal peptide, substance P,
somatostatin
, dynorphin-B and neurotensin, although present in some medial septal neurons, were never observed in neurons projecting to the hippocampus.
...
PMID:Neuropeptides and septo-hippocampal neurons: electrophysiological effects and distributions of immunoreactivity. 247 66
Earlier light microscopic data on afferent connections to the cholinergic forebrain neurons are reconsidered in the light of EM cross-identification of neurons and synapses by combinations of tracer and immunocytochemical techniques. Such studies suggest that brainstem monoaminergic afferents terminate on cholinergic forebrain neurons, and may modulate the activity of
choline acetyltransferase
levels in the postsynaptic neurons. A monosynaptic relationship between cholinergic forebrain neurons and neuropeptide Y and
somatostatin
containing axons is also supported by studies using double immunolabeling techniques at the EM level. These peptidergic afferents originate in part from locally arborizing neurons. Based upon the new data a circuit model for basal forebrain cholinergic neurons is proposed.
...
PMID:Afferent connections of the forebrain cholinergic projection neurons, with special reference to monoaminergic and peptidergic fibers. 253 86
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>